Impact of COVID-19 and suspension of colorectal cancer screening on incidence and stage distribution of colorectal cancers in the Netherlands

Impact of the COVID-19 pandemic on cancer diagnosis and resection in a COVID-19 low-burden country: Nationwide registration study in Japan

“…The broad spectrum of oncological care was suspended to deal with critical COVID-19 patients in some COVID-19 high-burden countries such as the Netherlnads. 1 , 2 This finding was totally compatible with a previous study from France, which reported decreased new case numbers of several cancers in 2020. 3 Nonetheless, how the pandemic damaged cancer care in COVID-19 low-burden countries, such as Japan, has not been assessed as a nationwide research project.…”

“…Similar to the observation in the Netherland by Dr. Toes-Zoutendijk and colleagues, 1 diagnosis of colon and rectal cancers were greatly decreased due to the pandemic in Japan. Besides, numbers of resection of colorectal cancers decreased ( Figure 1 B).…”

“…I read a recent article written by Dr. Toes-Zoutendijk and colleagues, which described how the coronavirus disease (COVID)-19 pandemic affected colorectal cancer screening and its incidence in the Netherlands. 1 The impact of the COVID-19 pandemic on cancer diagnosis and treatment is a serious concern for healthcare providers, policymakers, and the general public since cancer deaths are the leading causes of death in many countries. The broad spectrum of oncological care was suspended to deal with critical COVID-19 patients in some COVID-19 high-burden countries such as the Netherlnads.…”

Changes in the quality of cancer care as assessed through performance indicators during the first wave of the COVID-19 pandemic in 2020: a Scoping Review

“…Previous works addressed the impact of the COVID-19 pandemic on regional or national settings [5, 50], on specific cancers [5,6,169], specific stages of the care pathway [54], or treatment modalities [22]. This scoping review provides a summary of cancer care performance indicators, concerning various diseases, from early detection to the treatment phase of the care pathway, within OECD countries.…”

“…The COVID-19 pandemic has widely affected cancer care delivery. Substantial declines in the number of cancer diagnoses have been reported in the Netherlands [5,6], Spain [7], Belgium [8], and Denmark [9]. While trying to minimize the risk of COVID-19 disease in cancer patients, changes in practice were pursued by oncologists, according to each setting's capacity and recommendations released by oncology societies [10][11][12] .…”